Promising results from previous studies showed that angiogenic (placenta growth factor (PIGF)) and antiangiogenic (soluble fms-like tyrosine kanise-1 (sFlt1)) factors and uteroplacental flows could be used as diagnostic tests for superimposed preeclampsia on CKD. The gene discussed is PGF; the disease is chronic kidney disease.